UroLift is a New Minimally Invasive Approach to Treating Enlarged Prostate (BPH)

Published: 12 January 2016

UroLift is a new option for patients with an enlarged prostate looking for an alternative to drugs or major surgery. It is a minimally invasive approach to treating Benign Prostatic Hyperplasia (BPH) that lifts or holds the enlarged prostate tissue out of the way so it no longer blocks the urethra. There’s no cutting, heating or removal of prostate tissue.

Endoscopic results can be immediately confirmed post-procedure and patients may experience symptom relief as early as 2 weeks post-procedure.

The process offers immediate visible results which include:

  • Rapid relief of symptoms
  • No tissue removal or ablation
  • Minimal downtime
  • Preservation of sexual function

 

The UroLift Delivery device is inserted transurethrally through a rigid sheath under cytoscopic visualization in order to reach the targeted area of obstruction. The obstructing lobes are retracted by small permanent UroLift Implants which are deployed via a needle that comes out of the delivery device. Typically 4 to 5 UroLift implants are placed into the prostrate.

The Urolift procedure is offered at New Victoria Hospital by Consultant Urological Surgeon Mr Sarb Sandhu BSc(Hons) MBBS(Lon) MD(Lon) FRCS(Eng) FRCS Urol

Further information can be found at www.urolift.co.uk 

 

 

Share